1. Home
  2. SKYT vs ESPR Comparison

SKYT vs ESPR Comparison

Compare SKYT & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWater Technology Inc.

SKYT

SkyWater Technology Inc.

HOLD

Current Price

$16.36

Market Cap

939.6M

Sector

Technology

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

N/A

Current Price

$3.66

Market Cap

898.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SKYT
ESPR
Founded
1991
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
939.6M
898.5M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
SKYT
ESPR
Price
$16.36
$3.66
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$19.40
$6.86
AVG Volume (30 Days)
1.6M
6.4M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.62
N/A
Revenue
$346,587,000.00
$303,802,000.00
Revenue This Year
$28.48
$25.45
Revenue Next Year
$41.29
N/A
P/E Ratio
$6.24
N/A
Revenue Growth
0.19
2.83
52 Week Low
$5.67
$0.69
52 Week High
$24.23
$4.13

Technical Indicators

Market Signals
Indicator
SKYT
ESPR
Relative Strength Index (RSI) 46.23 54.41
Support Level $17.78 $3.72
Resistance Level $20.88 $4.13
Average True Range (ATR) 1.39 0.22
MACD -0.03 -0.04
Stochastic Oscillator 31.31 12.96

Price Performance

Historical Comparison
SKYT
ESPR

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: